Catalyst Wire Dossier Catalyst Wire Dossier

recombinant Epstein-Barr virus vaccine

unknown · Chinese University of Hong Kong
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant Epstein-Barr virus vaccine, covering 2021-07-28 to 2021-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy [Phase 2]

See pricing